Authentrics Inc Information

The CQI solution aggregates information from company systems to create a data lake of consolidated, centralized storage for raw, unstructured, semi-structured and structured data essential to high quality, efficient operations. Using these data, CQI predictive analytics generates millions of possible data combinations and deploys data mining, deep learning, statistics, modeling and artificial intelligence to uncover patterns that are otherwise invisible and unnoticed. These analytics help identify likely future events, foresee otherwise unpredictable outcomes, improve risk management, reduce operating losses, increase throughput and improve worker competencies. They provide near real-time actionable business intelligence displayed in configurable reports on resource competency, human and digital resources, key performance indicators (KPIs) and essential business outcomes. We drive quality and profitability at the intersection of employee performance and enterprise outcomes, regardless of work location, to contribute to economic recovery and growth. As experienced executive leaders with substantial P&L responsibility, we have a keen focus on the outcomes in human capital, systems and machine capability terms that drive the bottom line. Bruce has over 30 years of experience in managing complex, consequential, regulatory data and healthcare informatics. He was the founder, CEO, and Chairman of the Covalent Group from 1993 to 2000, guiding it from its founding to IPO as a publicly-traded, NASDAQ-listed company growing it to be one of the top-tier, publicly-traded CRO and healthcare delivery companies. Bruce has been actively involved in building technologies and applications to simplify complex data structures, including meta-data and tabular data search engines with visualization capabilities capable of linking disparate databases. His passion is to use data to optimize quality, business and employee outcomes. John has over 35 years of experience in device and pharmaceutical R&D for Johnson & Johnson, Novartis, ...